• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA 2019 Annual Report for Medical Device Registration

NMPA 2019 Annual Report for Medical Device Registration

Wednesday, 25 March 2020 / Published in Medical Device

NMPA 2019 Annual Report for Medical Device Registration

On 18.03.2020, the NMPA (National Medical Products Administration) issued the 2019 Annual Report for Medical Device Registration.

In 2019, the NMPA received a total of 9,104 applications for the initial registration, registration renewals and changes in licensing items of Class III (Domestic and Overseas) and Class II (Overseas) medical devices, an increase of 37.8% from 2018. Amongst the 9,104 applications, the NMPA approved a total of 8,471 applications with an increase of 53.2% as compared to 2018. Also, the NMPA handled a total of 1,383 filing applications of imported Class I medical devices, a decrease of 20.7% as compared to 2018.

Table 1. NMPA – No. of Applications and Approvals for Medical Devices and IVDs

Chart 1. NMPA – No. of Applications and Approvals for Medical Devices and IVDs

Chart 2. Percentage Distribution of Three Types of NMPA Approvals

Chart 3. Percentage Distribution of Approvals for Medical Devices and IVDs

Chart 4. NMPA – No. of New Registrations Approved from January 2013 to December 2019

Chart 5. NMPA – No. of New Registrations Approved from January 2019 to December 2019

In 2019, the NMPA approved 1,726 new registrations in total.

The provincial medical product administration (MPAs) authorities approved a total of 17,017 applications of China domestic Class II medical devices, an increase of 53.4% from 2018.

The municipal medical product administration (MPAs) authorities handled a total of 16,754 filing applications of China domestic Class I medical devices, decreased by 2.4% as compared to 2018.

China continues to focus on the supply of high-end, high-cost medical devices from abroad. The top five class II and III product groups of foreign origin to be registered in 2019 were:

1. Medical Imaging Equipment (81 Registrations)
2. Dental Instruments (57 Registrations)
3. Passive Implants Devices (50 Registrations)
4. Clinical Examination Instruments (41 Registrations)
5. Neurological and Cardiovascular Surgical Instruments (33 Registrations)

Chart 6. 2019 Top 5 Product Groups – Registration of Overseas Class II and III Medical Devices

The United States of America, Germany, Japan, Korea and Switzerland have the highest number of initial registrations for overseas medical devices, taking up to 75.4% of the total number of initial registrations for overseas medical devices.

Chart 7. 2019 Top 5 Countries – Exporting Medical Devices to China

Special Review Procedures for Innovative Medical Devices
NMPA received a total of 179 applications for special review and approval of innovative medical devices, including 31 applications for priority review. A total of 19 innovative medical devices were approved:

Imported
1) Micra Transcatheter Leadless Pacemaker system

Domestic
2) PET/CT imaging system
3) Nucleic acid amplification detection analyzer
4) Decellularized corneal implant
5) Left atrial appendage occluder system
6) Abdominal aorta stent-graft and delivery system
7) Bioabsorbable coronary rapamycin-eluting stent system
8) Porous tantalum bone filling material
9) Patient monitor
10) Left atrial appendage closure system
11) Intensity-modulated radiotherapy planning system software
12) Digital Mammography System
13) Transcatheter aortic valve system
14) Single-use intravascular imaging catheter
15) Non-Invasive Blood Glucose Meter
16) Implantable left ventricular assist system
17) Coronary angiographic blood flow reserve fraction measurement system
18) Disposable invasive pressure sensor
19) Positron emission and X-ray computed tomography scanning system

Further information concerning this topic can be obtained from:
Cisema (Hong Kong) Limited
Tel.: +852 3462 2483
info@cisema.com
www.cisema.com/en

Tagged under: IVDs, Medical Devices, NMPA Annual Report

What you can read next

From foreign- to China-made medical devices
2019 Annual Report, Strengthening Scheme and Updates on Medical Device Mandatory Standards
Unique Identification System (UDI) of Medical Devices

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP